Safety and Efficacy Clinical Trial
Official title:
NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia
This trial will explore the maximum tolerated dose of cord blood NKG2D CAR-NK in the treatment of recurrent refractory acute myeloid leukemia in a dose-escalation manner, and observe its clinical safety and efficacy.
This is a single arm, open-label, Phase 1 study initiated with 3 cohorts: Cohort 1: 2×10∧6/kg CAR-NK cells, 2 infusions on Day 0 and Day 7 Cohort 2: 6×10∧6/kg CAR-NK cells, 2 infusions on Day 0 and Day 7 Cohort 3: 18×10∧6/kg CAR-NK cells, 2 infusions on Day 0 and Day 7 ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04994210 -
Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCL
|
Phase 2 | |
| Completed |
NCT04621123 -
Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients
|
Phase 2 | |
| Recruiting |
NCT05140616 -
Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05349552 -
Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites
|
||
| Completed |
NCT03820596 -
Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCL
|
Phase 1/Phase 2 | |
| Completed |
NCT02018250 -
Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS)
|
Phase 1 | |
| Recruiting |
NCT04446806 -
Prevention and Treatment of Differentiation Syndrome in Patients With Acute Promyelocytic Leukemia
|
Phase 4 | |
| Recruiting |
NCT05556889 -
Safety and Analgesic Efficacy of a Modified Auriculotemporal Nerve Block
|
N/A | |
| Not yet recruiting |
NCT06244537 -
Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer
|
N/A | |
| Recruiting |
NCT03455972 -
Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCT
|
Phase 1/Phase 2 | |
| Completed |
NCT04785170 -
Clinical Study to Evaluate Safety and Efficacy of Amino Acid in Healthy Individuals
|
N/A | |
| Recruiting |
NCT04677452 -
Dose Exploration Study OF JWCAR129, BCMA-Targeted CART for RRMM
|
Phase 1 | |
| Completed |
NCT01305044 -
The HEALS Project - Health Education and Active Living for Surviving Seniors
|
Phase 2 | |
| Active, not recruiting |
NCT04646590 -
A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19
|
Phase 3 | |
| Recruiting |
NCT05021276 -
Basiliximab Combined With Ruxolitinib as Second-line Treatment of Grade 3-4 Steroid-resistant aGVHD
|
Phase 4 | |
| Not yet recruiting |
NCT05008666 -
Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH
|
Phase 2 | |
| Recruiting |
NCT06066840 -
Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement
|
Phase 4 | |
| Active, not recruiting |
NCT04852068 -
A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)
|
Phase 3 |